EXPE News Alert Expedia Inc (EXPE) 91.35 12/06/2014 22:03:58

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Expedia Inc (EXPE) 91.35 $EXPE

Priceline, Expedia boycott TripAdvisor's mobile bookings service
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 6:06PM CST

TRIP: 77.14 (-0.08), EXPE: 91.35 (+1.80), PCLN: 1,135.97 (-4.14)

Should Investors Buy A Ticket With Expedia?
Alpha Now at Thomson Reuters - Seeking Alpha - Fri Dec 05, 1:46PM CST
By Steven Carroll Source: Thomson Reuters Eikon Traveling the uptrend It's been a great time to be an Expedia (NASDAQ: EXPE ) investor, with the 85% return of the S&P 500 easily eclipsed by the Internet retailer. Indeed, despite...
EXPE: 91.35 (+1.80)

Stock Market Today: Indexes Close With Small Losses
at Investor's Business Daily - Thu Dec 04, 3:21PM CST
The stock market closed modestly lower Thursday after selling persisted through much of the afternoon. The Nasdaq, S&P 500 and Dow Jones industrial average each fell 0.1%. It wasn't much to alter the picture for the market, which has been working its...
JAZZ: 178.36 (+0.08), EXPE: 91.35 (+1.80)

Alibaba's Alitrip Stirs Up China Online Travel Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 12:30PM CST
When Alibaba Group Holding Limited (BABA) spun off its travel sites into a separate business called Alitrip in October, the growing importance of China's online travel booking market was highlighted.
BIDU: 232.72 (+1.91), EXPE: 91.35 (+1.80), LONG: 17.70 (+0.12), BABA: 107.90 (-1.27)

Priceline In An Acquisitive Mood: What Company Is Next After OpenTable?
Joseph Mwangi - at Seeking Alpha - Wed Dec 03, 3:00PM CST

AWAY: 31.92 (+0.07), TRIP: 77.14 (-0.08), EXPE: 91.35 (+1.80), YELP: 53.84 (-1.30), PCLN: 1,135.97 (-4.14)

TripAdvisor Shares Jump 8% on Insider Buying by CEO - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 1:24PM CST
Shares of TripAdvisor Inc. (TRIP) moved up nearly 8% , after its Chief Executive Officer (CEO) Stephen Kaufer revealed his latest investment in the company.
EXPE: 91.35 (+1.80), TRIP: 77.14 (-0.08), OWW: 8.33 (+0.25), PCLN: 1,135.97 (-4.14)

Apple, Facebook: Jason Weiner Of Fidelity's View
at Investor's Business Daily - Tue Dec 02, 5:19PM CST
Jason Weiner is like Green Bay Packers quarterback Aaron Rodgers. Season after season, he keeps performing at a high level. Since Feb. 2, 2007, when Weiner became the signal caller for the now $1.3 billion Fidelity Growth Discovery Fund and its...
AMZN: 312.63 (-4.30), HD: 99.64 (+0.69), FB: 76.36 (+1.12), TRIP: 77.14 (-0.08), ILMN: 189.90 (-0.93), HPQ: 39.55 (+0.48), PCLN: 1,135.97 (-4.14), ORCL: 41.93 (+0.04), EBAY: 54.81 (+0.14), GILD: 104.59 (+2.77), IBM: 163.27 (-0.78), CMG: 660.57 (-3.40), ALXN: 198.61 (+0.95), EXPE: 91.35 (+1.80), LOW: 64.86 (+0.31), GOOGL: 528.08 (-14.50), EMC: 30.33 (+0.01), ULTA: 129.75 (+4.01), SHW: 246.87 (-0.84), MSFT: 48.42 (-0.42), AAPL: 115.00 (-0.49), BABA: 107.90 (-1.27)

China's Online Travel Market Is A Money Magnet
at Investor's Business Daily - Tue Dec 02, 4:48PM CST
It's easy to see why Chinese e-commerce king Alibaba is reaching for a slice of China's online travel pie. Online travel tracker PhoCusWright says that gross bookings in China's online travel market hit $18.2 billion in 2013, making China second in...
EXPE: 91.35 (+1.80), CTRP: 44.91 (-2.28), BABA: 107.90 (-1.27)

Watch for Expedia to Potentially Pullback After Gaining 1.23% Yesterday
Comtex SmarTrend(R) - Tue Dec 02, 4:21PM CST
Expedia (NASDAQ:EXPE) traded in a range yesterday that spanned from a low of $86.62 to a high of $87.85. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $87.83 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EXPE: 91.35 (+1.80)

Expedia Set to Possibly Pullback After Yesterday's Rally of 1.23%
Comtex SmarTrend(R) - Tue Dec 02, 4:20PM CST
Expedia (NASDAQ:EXPE) traded in a range yesterday that spanned from a low of $86.62 to a high of $87.85. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $87.83 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EXPE: 91.35 (+1.80)

Why Priceline Should Consider Buying Its Online Rival TripAdvisor
at The Street - Tue Dec 02, 1:03PM CST
TripAdvisor stands to gain as Priceline considers expanding its portfolio through additional takeovers.
YHOO: 50.99 (+0.58), FB: 76.36 (+1.12), TRIP: 77.14 (-0.08), EXPE: 91.35 (+1.80), GOOG: 525.26 (-12.05), PCLN: 1,135.97 (-4.14), BABA: 107.90 (-1.27)

Internet Industry: Valuation, Momentum And Seasonality
Fred Piard - at Seeking Alpha - Tue Dec 02, 12:46PM CST

NFLX: 350.92 (+0.32), YHOO: 50.99 (+0.58), AMZN: 312.63 (-4.30), EBAY: 54.81 (+0.14), FB: 76.36 (+1.12), EXPE: 91.35 (+1.80), GOOGL: 528.08 (-14.50), FDN: 61.41 (+0.03), GOOG: 525.26 (-12.05), PCLN: 1,135.97 (-4.14)

Has Airbnb Acquired Pencil Labs?
Vikram Nagarkar - Amigobulls - Tue Dec 02, 7:33AM CST
The Airbnb Pencil Labs acquisition could add a social element to Airbnb's offerings and reinforce its messaging and mobile platform expertise.
AWAY: 31.92 (+0.07), TRIP: 77.14 (-0.08), EXPE: 91.35 (+1.80), PCLN: 1,135.97 (-4.14)

Amazon Travel: Amazon.com Inc's Answer To Wall Streets Calls For Higher Profits
Brian Nichols, The Motley Fool - Motley Fool - Mon Dec 01, 8:31AM CST
Travel insider site Skift recently reported that Amazon.com is planning to launch an online travel site to compete against companies like Expedia and The Priceline Group . While this might seem like just another service for Amazon.com, the...
AMZN: 312.63 (-4.30), EXPE: 91.35 (+1.80), PCLN: 1,135.97 (-4.14)

Expedia (EXPE) Upgraded From Hold to Buy
at The Street - Mon Dec 01, 8:01AM CST
Expedia (EXPE) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of A.
EXPE: 91.35 (+1.80)

3 Reasons Travelers Love Thanksgiving Weekend
Casey Kelly-Barton, The Motley Fool - Motley Fool - Fri Nov 28, 7:08AM CST
Thanksgiving travel isn't just about crowded airports and overbooked flights. Despite the holiday's reputation as a difficult and delay-prone travel period, it's a good time to find getaway bargains for the months ahead. Sabre -owned Travelocity, ...
AXP: 92.65 (+0.82), TRIP: 77.14 (-0.08), EXPE: 91.35 (+1.80), SABR: 18.93 (-0.30), OWW: 8.33 (+0.25)

Unplugged No More: 2014 Expedia/Egencia Mobile Index Reveals High Levels of Smartphone Dependence Among UAE Travelers
PR Newswire Europe - Wed Nov 26, 1:44PM CST
-- 25-Country Expedia/Egencia Study Examines How Mobile Devices Impact Travel
EXPE: 91.35 (+1.80)

Ctrip Q4 2014 Earnings Review
Kumar Abhishek - Amigobulls - Wed Nov 26, 8:28AM CST
Ctrip International reported its Q3 2014 earnings after the market close on 25th November 2014. Ctrip managed to beat both top and bottom line estimate.
EXPE: 91.35 (+1.80), CTRP: 44.91 (-2.28), PCLN: 1,135.97 (-4.14)

The Egencia Preferred Rates programme celebrates 10 years of delivering added hotel value as it reaches 10,000 enrolled properties
PR Newswire Europe - Wed Nov 26, 7:34AM CST
Egencia(R), the business travel company of the Expedia(R) group, is celebrating the 10-year anniversary of Egencia Preferred Rates (EPR), a successful programme which also recently reached the 10,000 mark for participating hotels.
EXPE: 91.35 (+1.80)

Expedia Allies with Amadeus to Offer Airline Branded Fares - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 24, 1:20PM CST
Expedia Inc. (EXPE) entered into a partnership with Amadeus, a leading global distribution system ("GDS" , in a bid to offer customers airline branded fares in 2015.
EXPE: 91.35 (+1.80), CTRP: 44.91 (-2.28), OWW: 8.33 (+0.25), PCLN: 1,135.97 (-4.14)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading